{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:30:14Z","timestamp":1780471814944,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T00:00:00Z","timestamp":1560124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T00:00:00Z","timestamp":1560124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12969-019-0333-6","type":"journal-article","created":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T13:03:06Z","timestamp":1560171786000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Early administration of adalimumab for paediatric uveitis due to Beh\u00e7et\u2019s disease"],"prefix":"10.1186","volume":"17","author":[{"given":"Tomona","family":"Hiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiko","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Kiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,10]]},"reference":[{"key":"333_CR1","doi-asserted-by":"publisher","unstructured":"Zeidan MJ, Saadoun D, Garrido M, Klatzmann D, Six A, Cacoub P. Beh\u00e7et\u2019s disease physiopathology: a contemporary review. Autoimmun Highlights. 2016. \n                    https:\/\/doi.org\/10.1007\/s13317-016-0074-1\n                    \n                  .","DOI":"10.1007\/s13317-016-0074-1"},{"key":"333_CR2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1756-185X.2010.01549.x","volume":"13","author":"F Davatchi","year":"2010","unstructured":"Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M, et al. Behcet\u2019s disease in Iran: analysis of 6500 cases. Int J Rheum Dis. 2010;13:367\u201373.","journal-title":"Int J Rheum Dis"},{"key":"333_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3109\/09273948.2011.555592","volume":"19","author":"L Atmaca","year":"2011","unstructured":"Atmaca L, Boyvat A, Yal\u00e7\u00ednda\u01e7 FN, Atmaca-Sonmez P, Gurler A. Beh\u00e7et disease in children. Ocul Immunol Inflamm. 2011;19:103\u20137.","journal-title":"Ocul Immunol Inflamm"},{"key":"333_CR4","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/rheumatology\/keq324","volume":"50","author":"I Kon\u00e9-Paut","year":"2011","unstructured":"Kon\u00e9-Paut I, Darce-Bello M, Shahram F, Gattorno M, Cimaz R, Ozen S, et al. Registries in rheumatological and musculoskeletal conditions. Paediatric Beh\u00e7et\u2019s disease: an international cohort study of 110 patients. One-year follow-up data. Rheumatology. 2011;50:184\u20138.","journal-title":"Rheumatology"},{"key":"333_CR5","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0022-3476(98)70368-3","volume":"132","author":"I Kone-Paut","year":"1998","unstructured":"Kone-Paut I, Yurdakul S, Bahabri SA, Shafae N, Ozen S, Ozdogan H, et al. Clinical features of Behcet\u2019s disease in children: an international collaborative study of 86 cases. J Pediatr. 1998;132:721\u20135.","journal-title":"J Pediatr"},{"key":"333_CR6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jaad.2007.10.452","volume":"58","author":"Y Karincaoglu","year":"2008","unstructured":"Karincaoglu Y, Borlu M, Toker SC, Akman A, Onder M, Gunasti S, et al. Demographic and clinical properties of juvenile-onset Beh\u00e7et\u2019s disease: a controlled multicenter study. J Am Acad Dermatol. 2008;58:579\u201384.","journal-title":"J Am Acad Dermatol"},{"key":"333_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0039-6257(01)00231-4","volume":"46","author":"A Ramsay","year":"2001","unstructured":"Ramsay A, Lightman S. Hypopyon Uveitis. Surv Ophthalmol. 2001;46:1\u201318.","journal-title":"Surv Ophthalmol"},{"key":"333_CR8","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1136\/annrheumdis-2015-208491","volume":"75","author":"I Kon\u00e9-Paut","year":"2016","unstructured":"Kon\u00e9-Paut I, Shahram F, Darce-Bello M, Cantarini L, Cimaz R, Gattorno M, et al. Consensus classification criteria for paediatric Beh\u00e7et\u2019s disease from a prospective observational cohort: PEDBD. Ann Rheum Dis. 2016;75:958\u201364.","journal-title":"Ann Rheum Dis"},{"key":"333_CR9","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S1474-4422(09)70015-8","volume":"8","author":"A Al-Araji","year":"2009","unstructured":"Al-Araji A, Kidd DP. Neuro-Beh\u00e7et\u2019s disease: epidemiology, clinical characteristics, and management. Lancet Neurol. 2009;8:192\u2013204.","journal-title":"Lancet Neurol"},{"key":"333_CR10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1136\/bjo.70.8.589","volume":"70","author":"D Benezra","year":"1986","unstructured":"Benezra D, Cohen E. Treatment and visual prognosis in Behcet\u2019s disease. Br J Ophthalmol. 1986;70:589\u201392.","journal-title":"Br J Ophthalmol"},{"key":"333_CR11","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1136\/ard.2007.080432","volume":"67","author":"G Hatemi","year":"2008","unstructured":"Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, et al. EULAR recommendations for the management of Beh\u00e7et disease. Ann Rheum Dis. 2008;67:1656\u201362.","journal-title":"Ann Rheum Dis"},{"key":"333_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","volume":"138","author":"I Tugal-Tutkun","year":"2004","unstructured":"Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M. Uveitis in Beh\u00e7et disease: an analysis of 880 patients. Am J Ophthalmol. 2004;138:373\u201380.","journal-title":"Am J Ophthalmol"},{"key":"333_CR13","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT, Atmaca LS, Becker MD, Brezin AP, et al. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509\u201316.","journal-title":"Am J Ophthalmol"},{"key":"333_CR14","doi-asserted-by":"publisher","unstructured":"Kone-Paut I, Georgin-Laviallec S, Galeotti C, Rossi-Semerano L, Hentgen V, Savey L, et al. New data in causes of autoinflammatory diseases. Jt Bone Spine. 2018. \n                    https:\/\/doi.org\/10.1016\/j.jbspin.2018.11.003\n                    \n                  .","DOI":"10.1016\/j.jbspin.2018.11.003"},{"key":"333_CR15","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1136\/annrheumdis-2017-212403","volume":"77","author":"FA Aeschlimann","year":"2018","unstructured":"Aeschlimann FA, Batu ED, Canna SW, Go E, G\u00fcl A, Hoffmann P, et al. A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease. Ann Rheum Dis. 2018;77:728\u201335.","journal-title":"Ann Rheum Dis"},{"key":"333_CR16","first-page":"59","volume":"10","author":"Y Mizushima","year":"1988","unstructured":"Mizushima Y. Recent research into Beh\u00e7et\u2019s disease in Japan. Int J Tissue React. 1988;10:59\u201365.","journal-title":"Int J Tissue React"},{"key":"333_CR17","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s10067-012-2082-5","volume":"31","author":"T Imagawa","year":"2012","unstructured":"Imagawa T, Takei S, Umebayashi H, Yamaguchi K, Itoh Y, Kawai T, et al. Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan. Clin Rheumatol. 2012;31:1713\u201321.","journal-title":"Clin Rheumatol"},{"key":"333_CR18","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1056\/NEJMoa1614160","volume":"376","author":"AV Ramanan","year":"2017","unstructured":"Ramanan AV, Dick AD, Jones AP, McKay A, Williamson PR, Compeyrot-Lacassagne S, et al. Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis. N Engl J Med. 2017;376:1637\u201346.","journal-title":"N Engl J Med"},{"key":"333_CR19","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/annrheumdis-2017-212089","volume":"77","author":"P Quartier","year":"2018","unstructured":"Quartier P, Baptiste A, Despert V, Allain-Launay E, Kon\u00e9-Paut I, Belot A, et al. ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis. Ann Rheum Dis. 2018;77:1003\u201311.","journal-title":"Ann Rheum Dis"},{"key":"333_CR20","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3899\/jrheum.171006","volume":"45","author":"V Cecchin","year":"2018","unstructured":"Cecchin V, Zannin ME, Ferrari D, Pontikaki I, Miserocchi E, Paroli MP, et al. Longterm safety and efficacy of adalimumab and infliximab for uveitis associated with juvenile idiopathic arthritis. J Rheumatol. 2018;45:1167\u201372.","journal-title":"J Rheumatol"},{"key":"333_CR21","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00417-018-3928-6","volume":"256","author":"I Deitch","year":"2018","unstructured":"Deitch I, Amer R, Tomkins-Netzer O, Habot-Wilner Z, Friling R, Neumann R, et al. The effect of anti-tumor necrosis factor alpha agents on the outcome in pediatric uveitis of diverse etiologies. Graefe\u2019s. Arch Clin Exp Ophthalmol. 2018;256:801\u20138.","journal-title":"Arch Clin Exp Ophthalmol"},{"key":"333_CR22","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jaapos.2013.06.009","volume":"17","author":"L Bravo-Ljubetic","year":"2013","unstructured":"Bravo-Ljubetic L, Peralta-Calvo J, Noval S, Pastora-Salvador N, Abelairas-G\u00f3mez J. Adalimumab therapy for refractory childhood uveitis. J AAPOS. 2013;17:456\u20139.","journal-title":"J AAPOS"},{"key":"333_CR23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1136\/bjo.2006.103721","volume":"91","author":"S Biester","year":"2007","unstructured":"Biester S, Deuter C, Michels H, Haefner R, Kuemmerle-Deschner J, Doycheva D, et al. Adalimumab in the therapy of uveitis in childhood. Br J Ophthalmol. 2007;91:319\u201324.","journal-title":"Br J Ophthalmol"},{"key":"333_CR24","first-page":"86","volume":"35","author":"G Guzelant","year":"2017","unstructured":"Guzelant G, Ucar D, Esatoglu SN, Hatemi G, Ozyazgan Y, Yurdakul S, et al. Infliximab for uveitis of Beh\u00e7et\u2019s syndrome: a trend for earlier initiation. Clin Exp Rheumatol. 2017;35:86\u20139.","journal-title":"Clin Exp Rheumatol"},{"key":"333_CR25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/09273948.2016.1239746","volume":"25","author":"H Keino","year":"2017","unstructured":"Keino H, Okada AA, Watanabe T, Nakayama M, Nakamura T. Efficacy of infliximab for early remission induction in refractory Uveoretinitis associated with Beh\u00e7et disease: a 2-year follow-up study. Ocul Immunol Inflamm. 2017;25:46\u201351.","journal-title":"Ocul Immunol Inflamm"},{"key":"333_CR26","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1002\/art.39667","volume":"68","author":"H Vallet","year":"2016","unstructured":"Vallet H, Seve P, Biard L, Baptiste Fraison J, Bielefeld P, Perard L, et al. Infliximab versus adalimumab in the treatment of refractory inflammatory uveitis: a multicenter study from the French uveitis network. Arthritis Rheumatol. 2016;68:1522\u201330.","journal-title":"Arthritis Rheumatol"},{"key":"333_CR27","first-page":"2011","volume-title":"In summary, this study could represent an in vitro model that may allow for further investigation of dis- ease mechanisms and therapeutic interventions in TEN","author":"T Difluprednate","year":"2013","unstructured":"Difluprednate T. In summary, this study could represent an in vitro model that may allow for further investigation of dis- ease mechanisms and therapeutic interventions in TEN, vol. 40; 2013. p. 2011\u20133."},{"key":"333_CR28","first-page":"132","volume":"32","author":"M Sawa","year":"1988","unstructured":"Sawa M, Tsurimaki Y, Tsuru T, Shimizu H. New quantitative method to determine protein concentration and cell number in aqueous in vivo. Jpn J Ophthalmol. 1988;32:132\u201342.","journal-title":"Jpn J Ophthalmol"},{"key":"333_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s10792-009-9310-2","volume":"30","author":"I Tugal-Tutkun","year":"2010","unstructured":"Tugal-Tutkun I, Herbort CP. Laser flare photometry: a noninvasive, objective, and quantitative method to measure intraocular inflammation. Int Ophthalmol. 2010;30:453\u201364.","journal-title":"Int Ophthalmol"},{"key":"333_CR30","first-page":"2120","volume-title":"Synergistic Uveitic effects of tumor necrosis","author":"LN Fleisher","year":"1992","unstructured":"Fleisher LN, Ferrell JD, Mcgahan MC. Synergistic Uveitic effects of tumor necrosis, vol. 33; 1992. p. 2120\u20137."},{"key":"333_CR31","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S0002-9394(03)00315-5","volume":"135","author":"JL Davis","year":"2003","unstructured":"Davis JL, Dacanay LM, Holland GN, Berrocal AM, Giese MJ, Feuer WJ. Laser flare photometry and complications of chronic uveitis in children. Am J Ophthalmol. 2003;135:763\u201371.","journal-title":"Am J Ophthalmol"},{"key":"333_CR32","first-page":"344","volume":"105","author":"GN Holland","year":"2007","unstructured":"Holland GN. A reconsideration of anterior chamber flare and its clinical relevance for children with chronic anterior uveitis (an American ophthalmological society thesis). Trans Am Ophthalmol Soc. 2007;105:344\u201364.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"333_CR33","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1755-3768.2011.02162.x","volume":"89","author":"T Christoph","year":"2011","unstructured":"Christoph T, Carsten H, Martin R, Arnd H. Elevated laser flare values correlate with complicated course of anterior uveitis in patients with juvenile idiopathic arthritis. Acta Ophthalmol. 2011;89:521\u20137.","journal-title":"Acta Ophthalmol"},{"key":"333_CR34","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1373\/clinchem.2015.242875","volume":"62","author":"E L\u00e1z\u00e1r-Moln\u00e1r","year":"2016","unstructured":"L\u00e1z\u00e1r-Moln\u00e1r E, Delgado JC. Immunogenicity assessment of tumor necrosis factor antagonists in the clinical laboratory. Clin Chem. 2016;62:1186\u201398.","journal-title":"Clin Chem"},{"key":"333_CR35","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/j.ophtha.2014.04.042","volume":"121","author":"M Takeuchi","year":"2014","unstructured":"Takeuchi M, Kezuka T, Sugita S, Keino H, Namba K, Kaburaki T, et al. Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Beh\u00e7et\u2019s disease: a multicenter study. Ophthalmology. 2014;121:1877\u201384.","journal-title":"Ophthalmology."},{"key":"333_CR36","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.ophtha.2018.02.020","volume":"125","author":"JL Mart\u00edn-Varillas","year":"2018","unstructured":"Mart\u00edn-Varillas JL, Calvo-R\u00edo V, Beltr\u00e1n E, S\u00e1nchez-Burs\u00f3n J, Mesquida M, Ad\u00e1n A, et al. Successful optimization of adalimumab therapy in refractory uveitis due to Beh\u00e7et\u2019s disease. Ophthalmology. 2018;125:1444\u201351.","journal-title":"Ophthalmology."}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-019-0333-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12969-019-0333-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-019-0333-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T23:21:23Z","timestamp":1591658483000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-019-0333-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,10]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["333"],"URL":"https:\/\/doi.org\/10.1186\/s12969-019-0333-6","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,10]]},"assertion":[{"value":"30 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval and consent was approved by the Hiroshima University IRB.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Both patients gave written consent to publish case details.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}